- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT07788521
Comparison of ACUVUE® OASYS MAX 1-Day Multifocal and DAILIES® AquaComfort Plus® Multifocal
This study is a 4-visit, multi-site, prospective, controlled, randomized, single-masked (subjects), two-arm parallel group, bilateral, dispensing clinical trial to compare the performance of the Test lens to the Control lens in terms of safety and efficacy.
연구 개요
연구 유형
등록 (추정된)
단계
- 해당 없음
연락처 및 위치
연구 연락처
- 이름: Study Contact
- 전화번호: 1-800-843-2020
- 이메일: tkarkkai@its.jnj.com
연구 장소
-
-
Florida
-
Longwood, Florida, 미국, 32779
- 완전한
- Pearson Research Center PA
-
-
Georgia
-
Roswell, Georgia, 미국, 30076
- 모집하지 않고 적극적으로
- VisualEyes
-
-
Missouri
-
St Louis, Missouri, 미국, 63144
- 모집하지 않고 적극적으로
- The Koetting Associates
-
-
New York
-
Jamestown, New York, 미국, 14701
- 모병
- Spectrum Eyecare
-
Manhattan, New York, 미국, 10022
- 모병
- Center for Ophthalmic and Vision Research/Eye Associates of New York
-
Vestal, New York, 미국, 13850
- 모집하지 않고 적극적으로
- Sacco Eye Group
-
-
Rhode Island
-
Warwick, Rhode Island, 미국, 02888
- 모집하지 않고 적극적으로
- Dr. David W. Ferris & Associates
-
-
Tennessee
-
Memphis, Tennessee, 미국, 38119
- 완전한
- Total Eye Care
-
-
Texas
-
Houston, Texas, 미국, 77030
- 모병
- Paradigm Research Center, LLC
-
Tyler, Texas, 미국, 75703
- 모집하지 않고 적극적으로
- Tyler Eye Associates
-
-
Virginia
-
Salem, Virginia, 미국, 24153
- 모병
- Botetourt Eyecare, LLC
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Potential subjects must satisfy all of the following criteria to be enrolled in the study:
- Read, understand, and sign the STATEMENT OF INFORMED CONSENT and receive a fully executed copy of the form.
- Appear able and willing to adhere to the instructions set forth in this clinical protocol.
- Be at least 40 years of age and not greater than 70 years of age at the time of consent.
- Own a wearable pair of spectacles if required for their distance vision.
- Be an adapted soft contact lens wearer in both eyes (i.e. worn lenses a minimum of 2 days per week for at least 6 hours per wear day, for 30 days or more duration).
- Either already be wearing a presbyopic contact lens correction (e.g., reading spectacles over contact lenses, multifocal or monovision contact lenses, etc.) or if not respond positively to at least one symptom on the "Presbyopic Symptoms Questionnaire".
- The subject's distance spherical equivalent refraction (vertex corrected if ≥-4.25 D) must be in the range of -1.50 D to -5.50 D in each eye.
- The subject's refractive cylinder must be ≤0.75 D in each eye.
- The subject's ADD power must be in the range of +0.75 D to +2.50 D.
- The subject must have distance best corrected visual acuity of 0.0 logMAR (20/20 Snellen, 5.0 on the China standard 5-point logMAR visual acuity scale) or better in each eye.
Potential subjects who meet any of the following criteria will be excluded from participating in the study:
- Be currently pregnant or lactating.
- Have any active or ongoing ocular or systemic allergies that may interfere with contact lens wear.
- Have been diagnosed with diabetes.
- Have any active or ongoing systemic disease, autoimmune disease, or use of medication, which may interfere with contact lens wear. This may include, but not be limited to, hyperthyroidism, Sjögren's syndrome, xerophthalmia, acne rosacea, Stevens-Johnson syndrome, and immunosuppressive diseases or any infectious diseases (e.g. hepatitis, tuberculosis).
- Have any previous, or planned, ocular or intraocular surgery (e.g. radial keratotomy, PRK, LASIK, lid procedures, dacryocystorhinostomy, peripheral iridotomy/iridectomy, cataract surgery, retinal surgery, etc.).
- Have a history of amblyopia, strabismus or binocular vision abnormality.
- Use of any of the following medications within 1 week prior to enrollment: oral retinoid, oral tetracyclines, anticholinergics, oral phenothiazines, oral/inhaled corticosteroids.
- Use of any ocular medication.
- Have a history of herpetic keratitis.
- Have a history of irregular cornea.
- Have a history of pathological dry eye.
- Have a history of glaucoma or glaucoma suspect.
- Have a history of any retinal disease/condition that may interfere with any of the study assessments or are not stable and have potential to progress during the study.
- Have participated in any contact lens or lens care product clinical trial within 15 days prior to study enrollment.
- Be an employee (e.g., Investigator, Coordinator, Technician) or immediate family member of an employee (including partner, child, parent, grandparent, grandchild, sibling of the employee or their spouse) of the clinical site.
- Have any known hypersensitivity or allergic reaction to sodium fluorescein.
- Have Grade 3 or greater palpebral conjunctival observations or Grade 2 or greater slit lamp findings (e.g. corneal edema, corneal vascularization, corneal staining, bulbar injection, etc.) on the ISO 11980 classification scale, or any other corneal or ocular abnormalities which would contraindicate contact lens wear.
- Have any current ocular infection or inflammation.
- Have intraocular pressure in one or both eyes >21mmHg
- Have signs of any retinal disease/conditions that may interfere with any of the study assessments or are not stable and have potential to progress during the study.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 하나의
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: Senofilcon A
Eligible subjects will be randomized to the Senofilcon A Lens for the duration of the study. |
ACUVUE® Oasys MAX 1-Day Multifocal |
|
활성 비교기: Nelfilcon A
Eligible subjects will be randomized to the Nelfilcon A Lens for the duration of the study. |
DAILIES® AquaComfort Plus® Multifocal |
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Incidence rate of study-lens related (i.e. related and possibly related) ocular adverse events.
기간: Up to 1-month follow-up
|
Up to 1-month follow-up
|
|
|
Mean binocular HLHC distance Visual Acuity
기간: At 1-week follow-up
|
Mean binocular HLHC VA at distance (4m) |
At 1-week follow-up
|
|
Mean binocular HLHC Intermediate Visual Acuity
기간: At 1-week follow-up
|
Mean binocular HLHC VA at Intermediate (64cm) |
At 1-week follow-up
|
|
Mean binocular HLHC Near Visual Acuity
기간: At 1-week follow-up
|
Mean binocular HLHC VA at Near (40cm) |
At 1-week follow-up
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Mean binocular HLHC distance Visual Acuity
기간: At 1-month follow-up
|
Mean binocular HLHC VA at distance (4m) |
At 1-month follow-up
|
|
Mean binocular HLHC Intermediate Visual Acuity
기간: At 1-month follow-up
|
Mean binocular HLHC VA at Intermediate (64cm) |
At 1-month follow-up
|
|
Mean binocular HLHC Near Visual Acuity
기간: At 1-month follow-up
|
Mean binocular HLHC VA at Near (40cm) |
At 1-month follow-up
|
|
Incidence rate of Slit Lamp Findings (SLF)
기간: Up to 1-month follow-up
|
Slit lamp findings will be assessed for each eye at all study visits (scheduled and unscheduled) by grade. SLFs will be evaluated and graded using the ISO 11980 Grading scale from 0 to 4, where Grade 0 represents the absence of findings and 1 to 4 representing successively worse findings (i.e., Grade 1 = trace, Grade 2 = mild, Grade 3 = moderate and Grade 4 = severe). |
Up to 1-month follow-up
|
공동 작업자 및 조사자
수사관
- 연구 책임자: Johnson & Johnson Vision Care, Inc. Clinical Trial, Johnson & Johnson Vision Care, Inc.
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
기타 연구 ID 번호
- CR-6560
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
IPD 계획 설명
Johnson & Johnson Medical Device Companies have an agreement with the Yale Open Data Access (YODA) to serve as the independent review panel for evaluation of requests for clinical study reports and participant level data from investigators and physicians for scientific research that will advance medical knowledge and public health. Requests for access to the study data can be submitted through the YODA Project site at http://yoda.yale.edu
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
미국에서 제조되어 미국에서 수출되는 제품
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .